About Prudentia Sciences
Prudentia Sciences is a company based in Cambridge (United States) founded in 2023.. Prudentia Sciences has raised $27 million across 2 funding rounds from investors including Google Ventures, Iaso Ventures and Virtue. Prudentia Sciences offers products and services including Prudentia Platform, Integrative Analytics, and Portfolio Optimization. Prudentia Sciences operates in a competitive market with competitors including Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group, among others.
- Headquarter Cambridge, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Prudentia
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$27 M (USD)
in 2 rounds
-
Latest Funding Round
$20 M (USD), Series A
Jan 07, 2026
-
Investors
Google Ventures
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prudentia Sciences
Prudentia Sciences offers a comprehensive portfolio of products and services, including Prudentia Platform, Integrative Analytics, and Portfolio Optimization. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for AI-driven asset diligence and valuation in drug development.
Tools for real-time simulation and risk assessment in biopharma investments.
AI-guided system for optimizing drug asset portfolios and deal strategies.
Funding Insights of Prudentia Sciences
Prudentia Sciences has successfully raised a total of $27M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $20.0M
-
First Round
First Round
(09 Jan 2025)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Series A - Prudentia Sciences | Valuation | McKesson Ventures | |
| Jan, 2025 | Amount | Series A - Prudentia Sciences | Valuation | Google Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prudentia Sciences
Prudentia Sciences has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Google Ventures, Iaso Ventures and Virtue. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in healthcare innovation startups.
|
Founded Year | Domain | Location | |
|
Pre-seed and seed-stage healthcare startups are funded by Virtue.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prudentia Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Prudentia Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prudentia Sciences Comparisons
Competitors of Prudentia Sciences
Prudentia Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Animal genomics is applied to healthcare advancements by Fauna Bio.
|
|
| domain | founded_year | HQ Location |
Data analytics and validation software for regulatory submission in the healthcare sector
|
|
| domain | founded_year | HQ Location |
AI-based drug discovery and clinical services are provided for biopharma.
|
|
| domain | founded_year | HQ Location |
AI-powered platforms for autonomous scientific research are developed.
|
|
| domain | founded_year | HQ Location |
Provider of clinical research data services for oncology & other therapeutic areas
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Prudentia Sciences
When was Prudentia Sciences founded?
Prudentia Sciences was founded in 2023 and raised its 1st funding round 2 years after it was founded.
Where is Prudentia Sciences located?
Prudentia Sciences is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Prudentia Sciences a funded company?
Prudentia Sciences is a funded company, having raised a total of $27M across 2 funding rounds to date. The company's 1st funding round was a Series A of $7M, raised on Jan 09, 2025.
What does Prudentia Sciences do?
Provider of AI-powered drug asset diligence and valuation. This platform offers real-time data-driven simulation and scenario planning to optimize asset valuation for deal terms, enabling faster decision-making and increased deal throughput. It rapidly synthesizes data room information into an asset assessment framework and product profile, facilitating comparisons with public and proprietary data and benchmarks. The platform also provides AI-guided product profiles and asset valuations to guide portfolio strategy and decision-making, and includes multi-disciplinary expert-in-the-loop deal analysis and modeling with real-time analytics. The system features traceable AI, evidence-based insights, and robust security measures.
Who are the top competitors of Prudentia Sciences?
Prudentia Sciences's top competitors include Fauna Bio, Predxbio and Lila Sciences.
What products or services does Prudentia Sciences offer?
Prudentia Sciences offers Prudentia Platform, Integrative Analytics, and Portfolio Optimization.
Who are Prudentia Sciences's investors?
Prudentia Sciences has 5 investors. Key investors include Google Ventures, Iaso Ventures, Virtue, McKesson Ventures, and SignalFire.